cytimidine

structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 05/01/2021 - "There was no significant correlation between IGF1 gene rs5742612 polymorphism and malignant tumor susceptibility [thymidine (T) vs. cytimidine (C), OR =0.99, 95% CI: 0.85-1.15, P=0.91; TC vs. CC: OR =1.03, 95% CI: 0.81-1.32, P=0.79; TT vs. CC: OR =0.92, 95% CI: 0.73-1.17, P=0.52; TT + TC =0.91; TC vs. CC: OR =0.97, 95% CI: 0.77-1.22, P=0.80; TT vs. TC + CC: OR =0.98, 95% CI: 0.81-1.18, P=0.83]. "
2.	Carcinoma (Carcinomatosis) 03/20/2007 - "To investigate the effect of dendritic cells (DCs) pulsed by oligonucleotide containing "un-methylated cytimidine-phosphodiester bond-guanylic acid" motif (CpG ODN) on ovarian carcinoma cells. "

1.	Thymidine
2.	Oligonucleotides
3.	Guanosine Monophosphate (5' Guanylic Acid)
4.	CPG-oligonucleotide